老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enanta Pharmaceuticals Inc.

13.16
-0.0700-0.53%
成交量：18.80萬
成交額：247.49萬
市值：3.82億
市盈率：-5.06
高：13.31
開：13.19
低：13.02
收：13.23
52周最高：17.15
52周最低：5.88
股本：2,901.85萬
流通股本：2,083.05萬
量比：0.87
換手率：0.90%
股息：- -
股息率：- -
每股收益(TTM):-2.6000
每股收益(LYR):-3.8381
淨資產收益率：-59.00%
總資產收益率：-11.84%
市淨率：3.28
市盈率(LYR):-3.43

資料載入中...

總覽公司新聞資訊公告
2020/06/30

重要事件披露

8-K - Current report
2020/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/03/04

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/02

重要事件披露

Current report, item 5.07
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2019/11/21

重要事件披露

Current report, items 2.02 and 9.01
2019/09/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/09

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/06

重要事件披露

Current report, items 2.02 and 9.01
2019/06/26

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/10

季度報告

Quarterly report [Sections 13 or 15(d)]
更多